Editorial
Subclinical Psychiatric Symptoms and the Brain: What Can Developmental Population Neuroimaging Bring to the Table?

https://doi.org/10.1016/j.jaac.2015.07.011Get rights and content

References (12)

There are more references available in the full text version of this article.

Cited by (6)

  • Psychosis Risk and Development: What Do We Know From Population-Based Studies?

    2020, Biological Psychiatry
    Citation Excerpt :

    For example, in the Philadelphia Neurodevelopmental Cohort (PNC), a positive predictive value of 0.51 was reported for initial screening of PSs (39), but in a small Irish youth sample, childhood PSs had a positive predictive value of > 0.59 for adolescent externalizing and internalizing problems (40). Population-based longitudinal studies on subclinical/subthreshold PSs in children and adolescents offer promise for identifying disease biomarkers that predict progression to overt mental illness (41). Ultimately, these efforts aim at improving early identification of at-risk youths to improve long-term functional outcomes.

  • Diffusion MRI of white matter microstructure development in childhood and adolescence: Methods, challenges and progress

    2018, Developmental Cognitive Neuroscience
    Citation Excerpt :

    Moreover, most available reports in pediatric populations are cross-sectional case-control studies – many with limited sample sizes – and often don’t include analyses of age-effects (but rather only matches or statistically controls for age). Subclinical manifestations of most mental health disorders exist in the general population, including in children and adolescents (White, 2015), and neuroimaging population studies and studies of children and adolescents with subclinical symptoms are not only important for understanding risk-factors or early manifestations of disorders, but also appear to support a dimensional perspective on several brain phenotypes associated with mental health. For example, individuals showing subclinical symptoms for psychosis spectrum disorders (clinical high-risk) and individuals with diagnosed relatives (genetic high-risk) have brain microstructural changes at least somewhat overlapping with those reported in clinical groups (Arat et al., 2015; O'Hanlon et al., 2015; Peters and Karlsgodt, 2015), and a recent longitudinal study showed how higher levels of anxiety and depression symptoms was associated with regionally reduced rates of FA development in typically developing youth (Albaugh et al., 2016).

This work was supported by ZonMw TOP grant 91211021.

Disclosure: Dr. White reports no biomedical financial interests or potential conflicts of interest.

View full text